Oslo, Norway, 25 February 2025 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's full-year 2024 interim report on Thursday 27 February 2025, 08:30am – 09:00am CET ...
A webcast replay of the presentation will be available from ... The clinical trials are sponsored by IO Biotech and conducted in collaboration with Merck, which is supplying pembrolizumab.
Oslo, Norway, 25 February 2025 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's full-year 2024 interim report on Thursday 27 February 2025, 08:30am - 09:00am CET (local ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果